Atika Capital Management LLC Penumbra Inc Transaction History

Atika Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$181.44 - $260.22 $816,480 - $1.17 Million	-4,500 Reduced 12.0%	33,000 $8.3 Million
Q3 2023 Nov 13, 2023	BUY	$240.69 - $338.77 $9.03 Million - $12.7 Million	37,500 New	37,500 $9.07 Million
Q3 2022 Nov 14, 2022	BUY	$120.36 - $205.88 $9.15 Million - $15.6 Million	76,000 New	76,000 $14.4 Million
Q2 2019 Aug 12, 2019	SELL	$124.65 - $167.39 $2.99 Million - $4.02 Million	-24,000 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$115.84 - $160.31 $2.78 Million - $3.85 Million	24,000 New	24,000 $3.53 Million
Q3 2018 Nov 14, 2018	SELL	$121.55 - $156.8 $2.73 Million - $3.53 Million	-22,500 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$112.2 - $165.95 $673,200 - $995,699	-6,000 Reduced 21.05%	22,500 $3.11 Million
Q1 2018 May 15, 2018	BUY	$84.6 - $126.1 $2.41 Million - $3.59 Million	28,500 New	28,500 $3.3 Million

372

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Atika Capital Management LLC with notifications on news.